OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus
Naoki Tajiri, Ike de la Peña, Sandra A. Acosta, et al.
CNS Neuroscience & Therapeutics (2016) Vol. 22, Iss. 4, pp. 306-315
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
Ching-Chieh Chou, Yi Zhang, Mfon Umoh, et al.
Nature Neuroscience (2018) Vol. 21, Iss. 2, pp. 228-239
Open Access | Times Cited: 511

TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia
Hilary C. Archbold, Kasey L. Jackson, Ayush Arora, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 137

Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis
Maria L. Elkjaer, Tobias Frisch, Richard Reynolds, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 78

The intersection of COVID-19 and cancer: signaling pathways and treatment implications
Zhi Zong, Yujun Wei, Jiang Ren, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 61

Exportin 1 inhibition as antiviral therapy
Md. Hafiz Uddin, Jeffrey A. Zonder, Asfar S. Azmi
Drug Discovery Today (2020) Vol. 25, Iss. 10, pp. 1775-1781
Open Access | Times Cited: 55

Traumatic injury compromises nucleocytoplasmic transport and leads to TDP-43 pathology
Eric N. Anderson, Andrés A. Morera, Sukhleen Kour, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 48

Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo
Trinayan Kashyap, Jackelyn Murray, Christopher J. Walker, et al.
Antiviral Research (2021) Vol. 192, pp. 105115-105115
Open Access | Times Cited: 44

Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review
Rami A. Al‐Horani, Srabani Kar
Viruses (2020) Vol. 12, Iss. 10, pp. 1092-1092
Open Access | Times Cited: 44

Selinexor and COVID-19: The Neglected Warden
Gomaa Mostafa‐Hedeab, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25

Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells
Lindsay Lundberg, Chelsea Pinkham, Cynthia de la Fuente, et al.
PLoS neglected tropical diseases (2016) Vol. 10, Iss. 11, pp. e0005122-e0005122
Open Access | Times Cited: 38

Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity
Yanzhuo Liu, Chenfan Duan, Wen Liu, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 11, pp. 3261-3276
Closed Access | Times Cited: 28

Characterization, optimization, and in vitro evaluation of cholesterol-free liposomes
Ahmet Doğan Ergin, Burcu Üner
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104468-104468
Closed Access | Times Cited: 9

Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-β and IL-6 Secretion
Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1273-1273
Open Access | Times Cited: 14

MiR‐483‐3p improves learning and memory abilities via XPO1 in Alzheimer's disease
Gang Luo, Xiaoyan Wang, Changya Liu
Brain and Behavior (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 13

The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and Mice
Rylie M. Hightower, Andrea L. Reid, Devin Gibbs, et al.
Molecular Therapy (2019) Vol. 28, Iss. 1, pp. 189-201
Open Access | Times Cited: 22

An Autism-Related, Nonsense Foxp1 Mutant Induces Autophagy and Delays Radial Migration of the Cortical Neurons
Xue Li, Xin Han, Xiaomeng Tu, et al.
Cerebral Cortex (2018) Vol. 29, Iss. 7, pp. 3193-3208
Closed Access | Times Cited: 19

The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson’s Disease by Inhibiting the NF-κB/NLRP3 Pathway
Shuhan Liu, Shengxiang Wang, Run-Ze Gu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11

An update to the CRM1 cargo/NES database NESdb
Ho Yee Joyce Fung, Ashley B. Niesman, Yuh Min Chook
Molecular Biology of the Cell (2021) Vol. 32, Iss. 6, pp. 467-469
Open Access | Times Cited: 12

Iduna protects HT22 cells by inhibiting parthanatos: The role of the p53-MDM2 pathway
Haoxiang Xu, Xin Li, Xiuquan Wu, et al.
Experimental Cell Research (2019) Vol. 384, Iss. 1, pp. 111547-111547
Closed Access | Times Cited: 12

In vivo KPT-350 treatment decreases cortical hyperexcitability following traumatic brain injury
David Cantu, Danielle Croker, Sharon Shacham, et al.
Brain Injury (2020) Vol. 34, Iss. 11, pp. 1489-1496
Closed Access | Times Cited: 5

Selinexor for the treatment of patients with relapsed or refractory multiple myeloma
Anum Babar, Maham Babar, Hina Zubair, et al.
Journal of Oncology Pharmacy Practice (2024) Vol. 30, Iss. 3, pp. 535-546
Closed Access

Antiviral Properties of Essential Oil Mixture: Modulation of E7 and E2 Protein Pathways in Human Papillomavirus (HPV) Infection
Burcu Üner, Ece Güler, Mustafa Emrah Vicir, et al.
Journal of Ethnopharmacology (2024) Vol. 341, pp. 119289-119289
Closed Access

Page 1 - Next Page

Scroll to top